Solventum (SOLV) Non-Current Deferred Tax Liability (2023 - 2026)
Solventum's (SOLV) quarterly Non-Current Deferred Tax Liability came in at $161.0 million in Q1 2026, down 28.76% YoY from $226.0 million in Q1 2025, and down 1.83% on a QoQ basis from $164.0 million in Q4 2025.
Solventum (SOLV) Non-Current Deferred Tax Liability (2023 - 2026) Analysis & Trends
Solventum (SOLV) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $161.0 million in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 28.76% year-over-year to $161.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161.0 million (down 28.76% YoY) and the FY2025 annual result came in at $164.0 million, down 27.11% from the prior year.
- Non-Current Deferred Tax Liability declined to $161.0 million in Q1 2026, from $164.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $448.0 million in Q4 2023 to a low of $161.0 million in Q1 2026.
- A 4-year average of $226.3 million and a median of $214.0 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability sank 49.78% — and 2025, when it grew 7.94%.
- Tracing SOLV's Non-Current Deferred Tax Liability over 4 years: stood at $448.0 million in 2023, then sank by 49.78% to $225.0 million in 2024, then decreased by 27.11% to $164.0 million in 2025, then declined by 1.83% to $161.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $161.0 million (Q1 2026), $164.0 million (Q4 2025), and $169.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 157.00 Mn |
| Jun 30, 2026 | 157.00 Mn |
| Mar 31, 2026 | 161.00 Mn |
| Mar 31, 2026 | 161.00 Mn |
| Dec 31, 2025 | 164.00 Mn |
| Dec 31, 2025 | 164.00 Mn |
| Sep 30, 2025 | 169.00 Mn |
| Sep 30, 2025 | 169.00 Mn |
| Jun 30, 2025 | 231.00 Mn |
| Jun 30, 2025 | 231.00 Mn |
| Mar 31, 2025 | 226.00 Mn |
| Mar 31, 2025 | 226.00 Mn |
| Dec 31, 2024 | 225.00 Mn |
| Dec 31, 2024 | 225.00 Mn |
| Sep 30, 2024 | 214.00 Mn |
| Sep 30, 2024 | 214.00 Mn |
| Jun 30, 2024 | 214.00 Mn |
| Jun 30, 2024 | 214.00 Mn |
| Mar 31, 2024 | 211.00 Mn |
| Mar 31, 2024 | 211.00 Mn |